Abstract
Context: In folk medicine the dried fruits of Elaeocarpus ganitrus Roxb. (Elaeocarpaceae), have been used in the treatment of melancholia, manic conditions and other psychological disorders.
Objective: To isolate the anxiolytic constituent of E. ganitrus using bioactivity guided fractionation.
Materials and methods: Crude extracts of E. ganitrus fruits were prepared using petroleum ether, chloroform and ethanol in a Soxhlet apparatus and finally the marc was boiled with water. Dried extracts were evaluated (50, 100, 200, 400 or 800 mg/kg, p.o) for antianxiety activity in mice using elevated plus maze apparatus (EPM). The most active ethanol extract (1000, 2000, 3000, 5000 mg/kg) was given to animals to observe acute toxicity, and observed for 14 days. Further the bioactive ethanol extract was subjected to column chromatography to isolate the bioactive constituent. The isolated constituent was further evaluated for antianxiety activity using EPM assay, light/dark chamber and double mirrored chamber model of anxiety. The structure of isolated compound was elucidated by IR, 1H NMR, and 13C NMR spectral data.
Results: Results showed that no mortality was reported even after 14 days. This indicated that ethanol extract was safe up to a single dose of 5000 mg/kg p.o. Antianxiety activity guided fractionation of ethanol extract led to the isolation of 3,3',4',5,7-pentahydroxyflavone. The above isolated bioactive compound (25 mg/kg, p.o) exhibited significant anxiolytic activity in mice using EPM assay, light/dark chamber and double mirrored chamber model of anxiety.
Conclusion: It is concluded that 3,3',4',5,7-pentahydroxyflavone is responsible for antianxiety activity of traditionally used E. ganitrus.
Keywords: Antianxiety, central nervous system, elaeocarpus, flavonoids, rudraksa, quercetin.
The Natural Products Journal
Title:Bioactivity Guided Isolation of Quercetin as Anxiolytic Compound from Elaeocarpus ganitrus Beads
Volume: 3 Issue: 3
Author(s): Balbir Singh, Vishal Sharma, Mohan Pal Singh Ishar and Anupam Sharma
Affiliation:
Keywords: Antianxiety, central nervous system, elaeocarpus, flavonoids, rudraksa, quercetin.
Abstract: Context: In folk medicine the dried fruits of Elaeocarpus ganitrus Roxb. (Elaeocarpaceae), have been used in the treatment of melancholia, manic conditions and other psychological disorders.
Objective: To isolate the anxiolytic constituent of E. ganitrus using bioactivity guided fractionation.
Materials and methods: Crude extracts of E. ganitrus fruits were prepared using petroleum ether, chloroform and ethanol in a Soxhlet apparatus and finally the marc was boiled with water. Dried extracts were evaluated (50, 100, 200, 400 or 800 mg/kg, p.o) for antianxiety activity in mice using elevated plus maze apparatus (EPM). The most active ethanol extract (1000, 2000, 3000, 5000 mg/kg) was given to animals to observe acute toxicity, and observed for 14 days. Further the bioactive ethanol extract was subjected to column chromatography to isolate the bioactive constituent. The isolated constituent was further evaluated for antianxiety activity using EPM assay, light/dark chamber and double mirrored chamber model of anxiety. The structure of isolated compound was elucidated by IR, 1H NMR, and 13C NMR spectral data.
Results: Results showed that no mortality was reported even after 14 days. This indicated that ethanol extract was safe up to a single dose of 5000 mg/kg p.o. Antianxiety activity guided fractionation of ethanol extract led to the isolation of 3,3',4',5,7-pentahydroxyflavone. The above isolated bioactive compound (25 mg/kg, p.o) exhibited significant anxiolytic activity in mice using EPM assay, light/dark chamber and double mirrored chamber model of anxiety.
Conclusion: It is concluded that 3,3',4',5,7-pentahydroxyflavone is responsible for antianxiety activity of traditionally used E. ganitrus.
Export Options
About this article
Cite this article as:
Singh Balbir, Sharma Vishal, Singh Ishar Pal Mohan and Sharma Anupam, Bioactivity Guided Isolation of Quercetin as Anxiolytic Compound from Elaeocarpus ganitrus Beads, The Natural Products Journal 2013; 3 (3) . https://dx.doi.org/10.2174/22103155113039990010
DOI https://dx.doi.org/10.2174/22103155113039990010 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Increase Signaling of Wnt/β-Catenin Pathway and Presence of Apoptosis in Cerebellum of Kindled Rats
CNS & Neurological Disorders - Drug Targets Targeting TRPs in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Opinion Paper: Post-surgical Delirium, Consciousness, and Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Design and Synthesis of New Selective P-gp Substrates and Inhibitors
Current Pharmaceutical Design Ligand based Drug Design of New Heterocyclic Imines of GABA Analogues: A Molecular Docking Approach for the Discovery of New GABA-AT Inhibitors
Central Nervous System Agents in Medicinal Chemistry Secondary Brain Injuries in Thalamus and Hippocampus after Focal Ischemia Caused by Mild, Transient Extradural Compression of the Somatosensori Cortex in the Rat
Current Neurovascular Research Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Topiramate Decelerates Bicarbonate-Driven Acid-Elimination of Human Neocortical Neurons: Strategic Significance for its Antiepileptic, Antimigraine and Neuroprotective Properties
CNS & Neurological Disorders - Drug Targets Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity
Central Nervous System Agents in Medicinal Chemistry From Anreps Phenomenon to Myocardial Hypertrophy: Role of the Na+/H+ Exchanger
Current Cardiology Reviews Design and Evaluation of Semicarbazones and Thiosemicarbazones as Novel Anticonvulsants
Central Nervous System Agents in Medicinal Chemistry Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives
Letters in Drug Design & Discovery Radionuclide Imaging in Drug Development
Current Pharmaceutical Design Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism
Current Drug Metabolism Editorial [Hot Topic: Adenosine-Based Modulation of Brain Activity (Guest Editor: DETLEV BOISON)]
Current Neuropharmacology Macrophage Derived Cystatin B/Cathepsin B in HIV Replication and Neuropathogenesis
Current HIV Research The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive Illness in the Elderly
Current Neuropharmacology Mesenchymal Stem Cells Targeting of Systemic Disorders in Age-related Macular Degeneration
Current Tissue Engineering (Discontinued) The Relationship Between Cleft Lip, Maxillary Hypoplasia, Hypoxia and Phenytoin
Current Pharmaceutical Design Design, Synthesis and Pharmacological Evaluation of N3 Aryl/ Heteroaryl Substituted 2-((Benzyloxy and Phenylthio) Methyl) 6,7- dimethoxyquinazolin-4(3H)-ones as Potential Anticonvulsant Agents
Medicinal Chemistry